WallStreetZenWallStreetZen

NASDAQ: NVOS
Novo Integrated Sciences Inc Earnings & Revenue

OverviewEarnings
DividendOwnership

NVOS past revenue growth

How has NVOS's revenue growth performed historically?
Company
16.91%
Industry
8.57%
Market
17.15%
NVOS's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
NVOS's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
NVOS's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

NVOS earnings and revenue history

Current Revenue
$13.7M
Current Earnings
-$12.1M
Current Profit Margin
-88.5%

NVOS Return on Equity

Current Company
-49.8%
Current Industry
-65.8%
Current Market
28.2%
NVOS's Return on Equity (-49.8%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when NVOS announces earnings.

NVOS Return on Assets

Current Company
-33.7%
Current Industry
4.9%
NVOS is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

NVOS Return on Capital Employed

Current Company
-46.71%
Current Industry
10.6%
NVOS's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

NVOS vs Medical Care Facility Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
NVOS$13.66M-$8.68M-$12.08M+8.68%N/A
RHE$17.16M$1.12M$39.51M-4.88%N/A
AIH$89.64MN/A-$11.25M-6.11%N/A
BACK$0.00-$8.89M-$9.42M-100.00%N/A
IONM$3.57M-$29.72M-$38.51M-62.58%N/A
View Top Medical Care Facility Stocks

NVOS earnings dates

Next earnings date
May 24, 2024

Novo Integrated Sciences Earnings & Revenue FAQ

What were NVOS's earnings last quarter?

On Invalid Date, Novo Integrated Sciences (NASDAQ: NVOS) reported Q1 2024 earnings per share (EPS) of -$0.16, up 72.88% year over year. Total Novo Integrated Sciences earnings for the quarter were -$2.75 million. In the same quarter last year, Novo Integrated Sciences's earnings per share (EPS) was -$0.59.

If you're new to stock investing, here's how to buy Novo Integrated Sciences stock.

What was NVOS's earnings growth in the past year?

As of Q2 2024, Novo Integrated Sciences's earnings has grown year over year. Novo Integrated Sciences's earnings in the past year totalled -$12.08 million.

What is NVOS's earnings date?

Novo Integrated Sciences's earnings date is Invalid Date. Add NVOS to your watchlist to be reminded of NVOS's next earnings announcement.

What was NVOS's revenue last quarter?

On Invalid Date, Novo Integrated Sciences (NASDAQ: NVOS) reported Q1 2024 revenue of $3.17 million up 24.02% year over year. In the same quarter last year, Novo Integrated Sciences's revenue was $2.56 million.

What was NVOS's revenue growth in the past year?

As of Q2 2024, Novo Integrated Sciences's revenue has grown 16.91% year over year. This is 8.34 percentage points higher than the US Medical Care Facilities industry revenue growth rate of 8.57%. Novo Integrated Sciences's revenue in the past year totalled $13.66 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.